ArticleWorld journal of surgical oncology2025
Short- and long-term outcomes of totally robotic versus robotic-assisted total gastrectomy for advanced gastric cancer: a single-center retrospective study.
Article in World journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Reported device problems and patient outcomes in da Vinci robotic robotic gastric and upper-gastrointestinal procedures: an FDA MAUDE database analysis.Journal of robotic surgery · 2026Article
- The rebirth of pancreas transplantation: an innovative, fully robotic, reproducible surgical technique.BMC surgery · 2026Review
- [Robotic gastrectomy: Research progress and practical challenges].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis research conducts a comparison of Totally Robotic Total Gastrectomy (TRTG) and Robot-Assisted Total Gastrectomy (RATG) to evaluate their relative outcomes in patients with advanced gastric cancer, providing evidence to guide individualized surgical strategy selection.
methodsWe retrospectively gathered clinical data from patients who underwent either TRTG or RATG between January 2015 and December 2021, totaling 204 participants. After applying Propensity Score Matching (PSM), the matched cohort consisted of 118 patients, with 59 individuals in each of the TRTG and RATG groups. The study then compared the short-term and long-term outcomes between these two groups.
resultsPost-matching, there were no significant baseline differences between the groups. Surgery duration and anastomosis duration were both longer in the TRTG group than in the RATG group. However, TRTG was associated with significantly reduced intraoperative blood loss, shorter times to postoperative mobilization, flatus, and eating, decreased hospital stay, smaller incision sizes, and lower postoperative stress responses compared to RATG. The RATG group harvested a higher number of lymph nodes. No significant differences were observed between the two groups regarding postoperative complications, proximal and distal margins, nerve invasion, vascular cancer thrombus, postoperative drainage output, and hospitalization costs. The three-year overall survival and disease-free survival rates were similar between both groups.
conclusionsTRTG offers a safer and more advantageous surgical option regarding short-term outcomes compared to RATG and may be considered a preferable choice for total gastrectomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.